China’s Fosun to end BioNTech’s COVID-19 vaccine trial, seek approval for another

BioNTech’s Chinese partner Shanghai Fosun Pharmaceutical Group does not plan to run further clinical trials of the German firm’s coronavirus vaccine candidate that has completed early-stage trials in …
( read original story …)